Should we screen for microalbuminuria in essential hypertension?
- 31 December 1999
- journal article
- editorial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (6) , 1139-1141
- https://doi.org/10.1016/s0272-6386(99)70023-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implicationsAmerican Journal of Kidney Diseases, 1999
- Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuriaDiabetologia, 1996
- Microalbuminuria and endothelial dysfunction in essential hypertensionPublished by Elsevier ,1994
- Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic PatientsAnnals of Internal Medicine, 1993
- Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.BMJ, 1991
- Glycaemia, arterial pressure and micro-albuminuria in Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1984
- Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretionActa Endocrinologica, 1982
- MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUSThe Lancet, 1982
- INCREASED URINARY ALBUMIN-EXCRETION RATE IN BENIGN ESSENTIAL HYPERTENSIONThe Lancet, 1974
- AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONSThe Lancet, 1963